MARKET

NURO

NURO

Neurometrix Inc
NASDAQ
3.820
-0.110
-2.80%
Pre Market: 3.860 +0.04 +1.05% 08:01 12/04 EST
OPEN
3.730
PREV CLOSE
3.930
HIGH
3.868
LOW
3.730
VOLUME
5
TURNOVER
0
52 WEEK HIGH
17.44
52 WEEK LOW
3.600
MARKET CAP
4.17M
P/E (TTM)
-5.4704
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NURO last week (1127-1201)?
Weekly Report · 2h ago
OPEN, AMPE and NURO are among pre market gainers
Open, ampe and nuro are among pre market gainers. Aditxt (adtx) and sxtc are among the top pre market movers. Salesforce (crm) is up 9% ahead of its q3 earnings release. Jfbr, cmnd, and
Seeking Alpha · 4d ago
Weekly Report: what happened at NURO last week (1120-1124)?
Weekly Report · 11/27 11:32
Health Care Sector Update for 11/20/2023: MIRA, PXMD, NURO
NASDAQ · 11/20 18:44
Neurometrix Inc: Current report
Press release · 11/20 15:04
Weekly Report: what happened at NURO last week (1113-1117)?
Weekly Report · 11/20 11:29
Weekly Report: what happened at NURO last week (1106-1110)?
Weekly Report · 11/13 11:22
Weekly Report: what happened at NURO last week (1030-1103)?
Weekly Report · 11/06 11:27
More
About NURO
NeuroMetrix, Inc. is a commercial-stage neurotechnology company based in Woburn, Massachusetts. The Company is engaged in designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. The Company has two principal product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. The Company’s DPNCheck is its testing technology for peripheral neuropathies. The Company’s Quell is its wearable neuromodulation technology for chronic pain. It refined approximately 200,000 chronic pain patients. Patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Webull offers Neurometrix Inc stock information, including NASDAQ: NURO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NURO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NURO stock methods without spending real money on the virtual paper trading platform.